Announcement
05 July 2024

Save the Date: World Cancer Congress 2026 in Hong Kong

UICC is very pleased to announce that the World Cancer Congress 2026 will take place from 24-26 September 2026 in Hong Kong. It will be organised in collaboration with the Hong Kong Anti-Cancer Society, a long-standing UICC member organisation.

"The Hong Kong Anti-Cancer Society is honored to be the co-hosting organisation, alongside UICC, for the World Cancer Congress 2026, uniting global leaders to advance cancer control and reduce the global burden through transformative efforts. We are dedicated to collaborating closely with UICC and other stakeholders to ensure the success of this significant event," said Patricia Chu, BBS, Chair of The Hong Kong Anti-Cancer Society.

UICC organises the World Cancer Congress every two years, taking the global event to UICC member countries around the world. Several thousand participants from more than 130 countries have attended the conferences in the past.

“We are confident that Hong Kong will provide an exceptional setting for the Congress," said Dr. Cary Adams, CEO, Union for International Cancer Control. Its cutting-edge facilities and commitment to health care excellence make it an ideal location. Together with the Hong Kong Anti-Cancer Society and all partners involved, we will shape an impactful and inspiring event."

Last update

Tuesday 04 February 2025

Share this page

Related content

Several people at an event in discussion, focus on a woman wearing a headscarf

The preliminary programme for the World Cancer Congress 2026 is now available, highlighting high‑level sessions curated by an Expert Programme Committee and aligned with the Congress themes. Abstract submissions, registration at the lowest rate and partnership opportunities remain open.

Two women and a man in suit receiving an award on stage

Researchers and professionals are invited to submit by 1 April 2026 abstracts that address key challenges in cancer prevention, treatment, and care, with the potential to attract media interest and a chance to shape global cancer control.